GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Lifted by Bay Colony Advisory Group Inc d b a Bay Colony Advisors

Bay Colony Advisory Group Inc d b a Bay Colony Advisors grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,297 shares of the company’s stock after buying an additional 153 shares during the period. Bay Colony Advisory Group Inc d b a Bay Colony Advisors’ holdings in GE HealthCare Technologies were worth $571,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Callan Family Office LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth about $1,344,000. E Fund Management Co. Ltd. lifted its position in shares of GE HealthCare Technologies by 50.8% in the fourth quarter. E Fund Management Co. Ltd. now owns 10,526 shares of the company’s stock worth $823,000 after buying an additional 3,545 shares during the last quarter. PFG Private Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth about $198,000. Raymond James Financial Inc. acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth about $73,472,000. Finally, Cullen Frost Bankers Inc. lifted its position in shares of GE HealthCare Technologies by 55.7% in the fourth quarter. Cullen Frost Bankers Inc. now owns 13,714 shares of the company’s stock worth $1,072,000 after buying an additional 4,908 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 1.4 %

GE HealthCare Technologies stock opened at $86.58 on Friday. The business has a 50 day moving average price of $86.63 and a two-hundred day moving average price of $86.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market cap of $39.59 billion, a price-to-earnings ratio of 20.00, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Citigroup boosted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.